West Virginia Pipe Trades Health & Welfare Fund v. Medtronic, Inc.
United States Court of Appeals for the Eighth Circuit
845 F.3d 384 (2016)
- Written by Sean Carroll, JD
Facts
Medtronic, Inc. (defendant) developed a procedure called INFUSE as an alternative to bone grafting. The U.S. Food and Drug Administration (FDA) approved the procedure based on several medical-journal articles discussing clinical trials of INFUSE. The trials had been run by Medtronic, and it was later revealed that the articles were written by doctors with financial interests in INFUSE. West Virginia Pipe Trades Health & Welfare Fund (the fund) (plaintiff), a Medtronic investor, brought a securities class action, alleging that Medtronic had engaged in a scheme to defraud investors based on Securities and Exchange Commission Rule 10b-5(a) and (c). The fund alleged that Medtronic paid the authors of the articles to downplay the downsides of INFUSE and overstate the shortcomings of bone grafting. The district court granted Medtronic’s motion for summary judgment. The fund appealed.
Rule of Law
Issue
Holding and Reasoning (Gruender, J.)
What to do next…
Here's why 788,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,200 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.